PATENT CLAIM ANALYSIS

Application Number: 15971633
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2019-04
Patent Classification: ["424", "130100"]

Abstract:
Diagnostics relating to C-type natriuretic and erythropoietin signal peptides and fragments, and kits, uses and applications therefore.

Claim (Index 30):
The composition of  claim 27 , wherein either the first or the second anti-EPOsp antibody, or antigen-binding fragment thereof, binds the EPOsp(18-27) peptide having an amino acid sequence consisting of SEQ ID NO:3.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 93.0
- Lexical Diversity: 1.25
- Patent Class: 424.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14691562', '13186447', '13863343', '12922438', '12922444']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7396679975590282
- 35 USC 102 Novelty (BERT): 0.5664663053581999
- Combined Prediction Score: 0.7223478283389454
- Mean Citation Score: 332.408358
- Max Citation Score: 454.96347
- Similarity Product: 348.09702639777123

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test